• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Important Safety Information: Dosing and Administration of Rabies Immune Globulin (Human), HyperRAB™ S/D Packaged in 2-ml Syringes

According to Talecris Biotherapeutics, three lots of HyperRAB™ S/D have been packaged and distributed in 2 mL uncalibrated syringes with fixed needles that may not permit administration of the recommended dosage when:

  • A dose less than 2 mL is required (e.g. for pediatric use)
  • A 2 mL (or less) dose must be injected over multiple sites
  • An alternate needle (different length or gauge) is required based on the patient weight and height (adult or child), wound characteristics and site of injection.

Talecris is sending revised instructions to end-users, to address appropriate dosing in the above circumstances, and is also posting these instructions on their website.

For additional questions, please call the Talecris Help Line at 919-412-1030 for 24 hour assistance.